Cheng; Ann-Joy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheng; Ann-Joy.The latest application filed is for "mir-520b sequence for inhibiting cancer growth and spread and medicine therefor".

Company Profile

0.4.12

Cheng; Ann-Joy - Taoyuan City TW
Cheng; Ann-Joy - Taoyuan County TW
Cheng; Ann-Joy - Taoyuan TW
CHENG; ANN-JOY - LINKOU SHIANG TW
Cheng; Ann-Joy - Linkou Township TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mir-520b Sequence For Inhibiting Cancer Growth And Spread And Medicine Therefor App 20170283808 - Cheng; Ann-Joy ; et al.	2017-10-05
Method Of Using Sequence Of Antagomir For Developing Medicine For Inhibiting Oral Cancer Cells From Spreading App 20150246069 - Cheng; Ann-Joy ; et al.	2015-09-03
Method Of Using Both Mir-196a And Mir-196b As Biomarkers For Detecting Oral Cancer App 20140030715 - Cheng; Ann-Joy ; et al.	2014-01-30
SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF App 20110008882 - CHENG; ANN-JOY ; et al.	2011-01-13
Labeled Molecule For Prognosing Tumor Grade Of Head And Neck Cancer And Method For The Same App 20110008821 - CHENG; Ann-Joy ; et al.	2011-01-13
Specific GRP78 expression-inhibition RNAi sequence, medicine thereof and method thereof Grant 7,829,695 - Cheng , et al. November 9, 2	2010-11-09
Specific GRP78 expression-inhibition RNAi sequence, medicine thereof and method thereof Grant 7,825,100 - Cheng , et al. November 2, 2	2010-11-02
Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression Grant 7,732,594 - Chang , et al. June 8, 2	2010-06-08
SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF App 20100009435 - CHENG; ANN-JOY ; et al.	2010-01-14
Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression Grant 7,622,456 - Chang , et al. November 24, 2	2009-11-24
Method on Clinical Applications in Head Neck Cancer by Using DSG3 Molecule for Predicting Malignant Degree of Cancer, Serving as a Molecular Target and Using RNA Jamming Sequence on Inhibition-Specific of DSG3 Expression App 20090233352 - Chang; Joseph Tung-Chieh ; et al.	2009-09-17
SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF App 20090181913 - CHENG; Ann-Joy ; et al.	2009-07-16
Labeled Molecule For Prognosing Tumor Grade Of Head Neck Cancer And Method For The Same App 20090181472 - CHENG; Ann-Joy ; et al.	2009-07-16
Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression App 20090029354 - Chang; Joseph Tung-Chieh ; et al.	2009-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.